Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Bio-Rad Laboratories, Inc. (BIO.B : NYSE)
 
 • Company Description   
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $284.88 Daily Weekly Monthly
20 Day Moving Average: 20 shares
Shares Outstanding: 27.21 (millions)
Market Capitalization: $7,752.19 (millions)
Beta: 0.81
52 Week High: $359.22
52 Week Low: $225.29
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.00% -0.61%
12 Week 15.31% 9.40%
Year To Date -12.51% -23.59%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1000 ALFRED NOBEL DR
-
HERCULES,CA -
USA		 ph: 510-724-7000
fax: 1-510-7415815		 investor_relations@bio-rad.com http://www.bio-rad.com
 
 • General Corporate Information   
Officers
Norman Schwartz - President and Director
Norman Schwartz - Chief Executive Officer and Chairman
Christine A. Tsingos - Vice President;Chief Financial Officer
Roop K. Lakkaraju - Chief Financial Officer and Executive Vice Preside
James R. Stark - Corporate Controller

Peer Information
Bio-Rad Laboratories, Inc. (CORR.)
Bio-Rad Laboratories, Inc. (RSPI)
Bio-Rad Laboratories, Inc. (CGXP)
Bio-Rad Laboratories, Inc. (BGEN)
Bio-Rad Laboratories, Inc. (GTBP)
Bio-Rad Laboratories, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 090572108
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 10/29/25
Share - Related Items
Shares Outstanding: 27.21
Most Recent Split Date: 3.00 (2.00:1)
Beta: 0.81
Market Capitalization: $7,752.19 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 10/29/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: 28.32
PEG Ratio: -
Price Ratios
Price/Book: 1.09
Price/Cash Flow: 27.41
Price / Sales: 3.04
EPS Growth
vs. Year Ago Period: -16.08%
vs. Previous Quarter: 2.76%
Sales Growth
vs. Year Ago Period: 2.06%
vs. Previous Quarter: 11.31%
ROE
09/30/25 - -
06/30/25 - 4.01
03/31/25 - 4.32
ROA
09/30/25 - -
06/30/25 - 2.82
03/31/25 - 3.03
Current Ratio
09/30/25 - -
06/30/25 - 5.12
03/31/25 - 5.99
Quick Ratio
09/30/25 - -
06/30/25 - 3.67
03/31/25 - 4.43
Operating Margin
09/30/25 - -
06/30/25 - 10.94
03/31/25 - 11.69
Net Margin
09/30/25 - -
06/30/25 - 12.50
03/31/25 - -85.16
Pre-Tax Margin
09/30/25 - -
06/30/25 - 17.62
03/31/25 - -108.23
Book Value
09/30/25 - -
06/30/25 - 261.96
03/31/25 - 245.45
Inventory Turnover
09/30/25 - -
06/30/25 - 1.53
03/31/25 - 1.50
Debt-to-Equity
09/30/25 - -
06/30/25 - 0.17
03/31/25 - 0.18
Debt-to-Capital
09/30/25 - -
06/30/25 - 14.42
03/31/25 - 15.24
 

Powered by Zacks Investment Research ©